Prognostic Value of p53 and Proliferating Cell Nuclear Antigen Expression in Endometrial Carcinoma

By Hamel N.W.   Sebo T.J.   Wilson T.O.   Keeney G.L.   Roche P.C.   Suman V.J.   Hu T.C.   Podratz K.C.  

Gynecologic Oncology, Vol. 62, Iss. 2, 1996-08 ,pp. : 192-198

Academic Press

Access to resources Recommend Favorite

Impact of Ethnicity on the Incidence of High-Risk Endometrial Carcinoma

By Plaxe S.C.   Saltzstein S.L.  

Gynecologic Oncology, Vol. 65, Iss. 1, 1997-04 ,pp. : 8-12

Elsevier

Access to resources Recommend Favorite

Clinical Signficance of p53, Proliferating Cell Nuclear Antigen and bcl-2 Expression in Bladder Transitional Cell Carcinoma

By Zhu Zhaohui   Cheng Ping   Zeng Fuqing   Lu Gongcheng   Xing Shian  

The Chinese-German Journal of Clinical Oncology, Vol. 3, Iss. 1, 2004-03 ,pp. : 20-23

Springer Publishing Company

Access to resources Recommend Favorite

Proliferating cell nuclear antigen (PCNA): ringmaster of the genome

By Paunesku T.   Mittal S.   Protić M.   Oryhon J.   Korolev S. V.   Joachimiak A.   Woloschak G. E.  

International Journal of Radiation Biology, Vol. 77, Iss. 10, 2001-10 ,pp. : 1007-1021

Informa Healthcare

Access to resources Recommend Favorite

Presence of Oncogenic HPV DNAs in Cervical Carcinoma Tissues and Pelvic Lymph Nodes Associating with Proliferating Cell Nuclear Antigen Expression

By Park J.S.   Rhyu K.S.   Kim C.J.   Kim H.S.   Han K.T.   Ahn H.K.   Kim S.J.   Namkoong S.E.  

Gynecologic Oncology, Vol. 60, Iss. 3, 1996-03 ,pp. : 418-423

Academic Press

Access to resources Recommend Favorite